Medicofarma Biotech SA (WSE: MDB)
Poland
· Delayed Price · Currency is PLN 0.366
+0.006 (1.67%)
At close: Jan 21, 2025
Medicofarma Biotech Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -3.17 | -3.44 | -1.59 | -0.22 | -0.92 | -0.34 | Upgrade
|
| Depreciation & Amortization | 1.73 | 2.08 | 1.75 | 0.95 | 0.04 | 0.08 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0.07 | 0.13 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.02 | Upgrade
|
| Other Operating Activities | 0.77 | 0.79 | 0.05 | 0.01 | - | -0 | Upgrade
|
| Change in Accounts Receivable | 0.18 | 0.2 | 0.86 | -1.29 | 0.49 | 0.03 | Upgrade
|
| Change in Inventory | -0 | 0.14 | 0.41 | -0.42 | 0.21 | -0.01 | Upgrade
|
| Change in Other Net Operating Assets | 0.39 | 0.23 | -0.51 | 2.84 | -0.26 | -0.11 | Upgrade
|
| Operating Cash Flow | -0.09 | 0.01 | 0.96 | 1.82 | -0.31 | -0.38 | Upgrade
|
| Operating Cash Flow Growth | - | -99.24% | -47.11% | - | - | - | Upgrade
|
| Capital Expenditures | -0.37 | -1.11 | -1.21 | -2.3 | - | - | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0 | - | Upgrade
|
| Other Investing Activities | - | - | - | -13.71 | - | - | Upgrade
|
| Investing Cash Flow | -0.37 | -1.11 | -1.21 | -16.01 | 0.34 | -0.14 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 0.23 | 0.2 | Upgrade
|
| Long-Term Debt Issued | - | 1.11 | 0.69 | - | - | - | Upgrade
|
| Total Debt Issued | 1.04 | 1.11 | 0.69 | - | 0.23 | 0.2 | Upgrade
|
| Long-Term Debt Repaid | - | -0.51 | - | -0.39 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 0.45 | 0.6 | 0.69 | -0.39 | 0.23 | 0.2 | Upgrade
|
| Issuance of Common Stock | - | - | - | 14.65 | - | - | Upgrade
|
| Other Financing Activities | - | - | -0.01 | -0.01 | -0.3 | 0.02 | Upgrade
|
| Financing Cash Flow | 0.45 | 0.6 | 0.68 | 14.25 | -0.07 | 0.23 | Upgrade
|
| Net Cash Flow | -0.01 | -0.5 | 0.43 | 0.05 | -0.04 | -0.29 | Upgrade
|
| Free Cash Flow | -0.46 | -1.1 | -0.25 | -0.48 | -0.31 | -0.38 | Upgrade
|
| Free Cash Flow Margin | -42.94% | -146.38% | -5.83% | -14.48% | -8.54% | -11.96% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.00 | -0.01 | -0.05 | -0.06 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.01 | 0.02 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -1.41 | -0.79 | 0.99 | -1.37 | 0.2 | -0.25 | Upgrade
|
| Unlevered Free Cash Flow | -1.32 | -0.68 | 1 | -1.36 | 0.21 | -0.24 | Upgrade
|
| Change in Net Working Capital | 1.19 | 0.02 | -1.44 | -0.16 | -0.4 | 0.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.